Skip to content
10-Q

Quarterly Report

Surmodics, Inc.

0000950170-25-010806

← back to feed
Filed
Jan 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Jan 27, 2025 14.3M sh
Shares Diluted Q1 2025 · Dec 31, 2024 14.23M sh
Shares Diluted Q1 2025 · Dec 31, 2023 14.1M sh
Capex Q1 2025 · Dec 31, 2024 $302K
Capex Q1 2025 · Dec 31, 2023 $720K
Operating Cash Flow Q1 2025 · Dec 31, 2024 −$7.89M
Operating Cash Flow Q1 2025 · Dec 31, 2023 −$8.79M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $30.15M
Cash And Equivalents Q1 2025 · Sep 30, 2024 $36.12M
Stockholders Equity Q1 2025 · Dec 31, 2024 $111.77M
Stockholders Equity Q1 2025 · Sep 30, 2024 $118.9M
Stockholders Equity Q1 2025 · Dec 31, 2023 $122.15M
Stockholders Equity Q1 2025 · Sep 30, 2023 $119.91M
Current Liabilities Q1 2025 · Dec 31, 2024 $13.19M
Current Liabilities Q1 2025 · Sep 30, 2024 $20.54M
Total Liabilities Q1 2025 · Dec 31, 2024 $51.97M
Total Liabilities Q1 2025 · Sep 30, 2024 $59.67M
Current Assets Q1 2025 · Dec 31, 2024 $71.85M
Current Assets Q1 2025 · Sep 30, 2024 $81.3M
Total Assets Q1 2025 · Dec 31, 2024 $163.74M
Total Assets Q1 2025 · Sep 30, 2024 $178.56M
Eps Diluted Q1 2025 · Dec 31, 2024 −$0.26
Eps Diluted Q1 2025 · Dec 31, 2023 −$0.06
Eps Basic Q1 2025 · Dec 31, 2024 −$0.26
Eps Basic Q1 2025 · Dec 31, 2023 −$0.06
Sga Expense Q1 2025 · Dec 31, 2024 $15.17M
Sga Expense Q1 2025 · Dec 31, 2023 $12.54M
Net Income Q1 2025 · Dec 31, 2024 −$3.65M
Net Income Q1 2025 · Dec 31, 2023 −$786K
Operating Income Q1 2025 · Dec 31, 2024 −$2.48M
Operating Income Q1 2025 · Dec 31, 2023 −$322K
Cost Of Revenue Q1 2025 · Dec 31, 2024 $7.43M
Cost Of Revenue Q1 2025 · Dec 31, 2023 $8.8M
Revenue Q1 2025 · Dec 31, 2024 $29.92M
Revenue Q1 2025 · Dec 31, 2023 $30.55M